Maria Mariano

Dr. Maria Mariano


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Dermatologic Surgery
Verified
Journal Article
Closed access
PDF file
NCNorma Cameli
Norma Cameli
MMMaria Mariano
Maria Mariano
ICIole Cordone
Iole Cordone
EAElva Abril
Elva Abril
SMSerena Masi
Serena Masi
MFMaria Laura Foddai
Maria Laura Foddai
BACKGROUND: Platelet-rich plasma (PRP) is an emerging treatment in dermatology recently proposed for skin rejuvenation. OBJECTIVE: To evaluate the efficacy and safety of autologous pure PRP dermal injections on facial skin rejuvenation, investigating the cellularity of PRP samples. MATERIALS AND METHODS: Twelve patients underwent 3 sessions of PRP injection at 1-month intervals. The clinical and instrumental outcomes were evaluated before (T0) and 1 month (T1) after the end of treatment by means of transepidermal water loss, corneometry, Cutometer, Visioscan, and Visioface. A flow cytometry characterization on PRP and peripheral blood (PB) samples was performed. RESULTS: Clinical and patient evaluation showed improvement of skin texture. Skin gross elasticity, skin smoothness parameters, skin barrier function, and capacitance were significantly improved. No difference between PRP and PB lymphocyte immunological asset was observed. A leukocyte population (mainly CD3+) and neutrophils depletion were documented in all the PRP samples. CONCLUSION: This instrumental study demonstrated that PRP poor in leukocytes can provide objective improvements in skin biostimulation. Flow cytometry showed no variability among the PRP samples using a reproducible separation system and a low content in proinflammatory cells. Although a pilot study, it may be helpful for future investigations on PRP cellularity.

28 May 2012 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
Gabriella FabbrociniGabriella Fabbrocini
Gabriella Fabbrocini
NCNorma Cameli
Norma Cameli
MRMaria Concetta Romano
Maria Concetta Romano
MMMaria Mariano
Maria Mariano
LPLuigia Panariello
Luigia Panariello
GMGiuseppe Monfrecola
Giuseppe Monfrecola
New chemotherapic agents and new protocols in oncology have led to an increasing survival rate in patients affected by tumors. However, this increased use has been accompanied by a growth in the incidence of cutaneous side effects and a worsening of patients’ quality of life. Appropriate management of skin toxicity associated with chemotherapic agents is therefore necessary for suitable drug administration and to improve quality of life and clinical outcomes.

6 May 2021 in Drug Safety
Verified
Journal Article
Closed access
PDF file
MSMartina Silvestri
Martina Silvestri
ACAntonio Cristaudo
Antonio Cristaudo
AMAldo Morrone
Aldo Morrone
CMClaudia Messina
Claudia Messina
LBLuigi Bennardo
Luigi Bennardo
NCNorma Cameli
Norma Cameli

18 February 2019 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
AFAngela Filoni
Angela Filoni
MMMaria Mariano
Maria Mariano
NCNorma Cameli
Norma Cameli

1 May 2014 in Dermatologic Surgery
Verified
Journal Article
Closed access
NCNorma Cameli
Norma Cameli
MMMaria Mariano
Maria Mariano
MSMirko Serio
Mirko Serio
Ardigo MarcoArdigo Marco
Ardigo Marco

18 October 2007 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Gabriella FabbrociniGabriella Fabbrocini
Gabriella Fabbrocini
ABAnna Balato
Anna Balato
ORO Rescigno
O Rescigno
MMMaria Mariano
Maria Mariano
MSM Scalvenzi
M Scalvenzi
BBB Brunetti
B Brunetti